Cargando…

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

Alterations of Eph receptor tyrosine kinases are frequent events in human cancers. Genetic variations of EPHB6 have been described but the functional outcome of these alterations is unknown. The current study was conducted to screen for the occurrence and to identify functional consequences of EPHB6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bulk, Etmar, Yu, Jun, Hascher, Antje, Koschmieder, Steffen, Wiewrodt, Rainer, Krug, Utz, Timmermann, Bernd, Marra, Alessandro, Hillejan, Ludger, Wiebe, Karsten, Berdel, Wolfgang E., Schwab, Albrecht, Müller-Tidow, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514309/ https://www.ncbi.nlm.nih.gov/pubmed/23226491 http://dx.doi.org/10.1371/journal.pone.0044591

Ejemplares similares

The Role of TRP Channels in the Metastatic Cascade
por: Fels, Benedikt, et al.
Publicado: (2018)

Functional expression of mitochondrial K(Ca)3.1 channels in non-small cell lung cancer cells
por: Bulk, Etmar, et al.
Publicado: (2022)

Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment
por: Marra, Alessandro, et al.
Publicado: (2011)

Feasibility of Azacitidine Added to Standard Chemotherapy in Older Patients with Acute Myeloid Leukemia — A Randomised SAL Pilot Study
por: Krug, Utz, et al.
Publicado: (2012)

K(Ca)3.1 channel inhibition leads to an ICAM-1 dependent increase of cell-cell adhesion between A549 lung cancer and HMEC-1 endothelial cells
por: Bulk, Etmar, et al.
Publicado: (2017)

Co‐staining of K(Ca)3.1 Channels in NSCLC Cells with a Small‐Molecule Fluorescent Probe and Antibody‐Based Indirect Immunofluorescence
por: Brömmel, Kathrin, et al.
Publicado: (2020)

Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia
por: Schemionek, Mirle, et al.
Publicado: (2015)

Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions
por: Bäumer, Nicole, et al.
Publicado: (2014)

A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis
por: Bäumer, Nicole, et al.
Publicado: (2015)

Role of the Intracellular Sodium Homeostasis in Chemotaxis of Activated Murine Neutrophils
por: Najder, Karolina, et al.
Publicado: (2020)

K(Ca) channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)
por: Glaser, Felix, et al.
Publicado: (2021)

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma
por: Lee, Yen-Ching, et al.
Publicado: (2005)

Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus
por: Henkemeyer, Mark, et al.
Publicado: (2003)

Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K(Ca)3.1) channels in vivo
por: Brömmel, Kathrin, et al.
Publicado: (2021)

Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer
por: Stephenson, Sally-Anne, et al.
Publicado: (2001)

NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration
por: Cui, Chunhong, et al.
Publicado: (2020)

Construction and Application of an Inducible System for Homogenous Expression Levels in Bulk Cell Lines
por: Yu, Jun, et al.
Publicado: (2009)

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer
por: Ferguson, Benjamin D., et al.
Publicado: (2015)

Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021)

A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia
por: Schliemann, Christoph, et al.
Publicado: (2016)

pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology
por: Pethő, Zoltán, et al.
Publicado: (2020)

AB137. Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas
por: Wang, Longxin, et al.
Publicado: (2016)

Ubiquitin ligase and signalling hub MYCBP2 is required for efficient EPHB2 tyrosine kinase receptor function
por: Chang, Chao, et al.
Publicado: (2023)

The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome
por: Kumar, S R, et al.
Publicado: (2007)

The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target
por: Ferguson, Benjamin D., et al.
Publicado: (2013)

Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4
por: Stephenson, Sally-Anne, et al.
Publicado: (2015)

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
por: Mimche, Patrice N., et al.
Publicado: (2018)

The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signalling hubs
por: Liang, Lung-Yu, et al.
Publicado: (2021)

Reelin induces EphB activation
por: Bouché, Elisabeth, et al.
Publicado: (2013)

The Roles of EphB2 in Cancer
por: Liu, Wei, et al.
Publicado: (2022)

Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity
por: Miyamoto, Takashi, et al.
Publicado: (2016)

The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-β8 in prostate cancer cells
por: Mertens-Walker, Inga, et al.
Publicado: (2015)

Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4
por: Lian, Haifeng, et al.
Publicado: (2018)

Structure of the EphB6 receptor ectodomain
por: Mason, Emilia O., et al.
Publicado: (2021)

Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2020)

The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder
por: Li, Xiuqing, et al.
Publicado: (2014)

Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation
por: Mimche, Patrice N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_etr35e5bv62ivdj1rm3eifp10n